GSA Capital Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,083
| Closed | -$323K | – | 1669 |
|
|
2023
Q4 | $323K | Sell |
9,083
-1,942
| -18% | -$69.1K | 0.03% | 1074 |
|
|
2023
Q3 | $328K | Sell |
11,025
-24,163
| -69% | -$719K | 0.03% | 1023 |
|
|
2023
Q2 | $634K | Buy |
35,188
+5,733
| +19% | +$103K | 0.06% | 586 |
|
|
2023
Q1 | $473K | Buy |
+29,455
| New | +$473K | 0.05% | 748 |
|
|
2022
Q2 | – | Sell |
-14,897
| Closed | -$327K | – | 1450 |
|
|
2022
Q1 | $327K | Buy |
14,897
+2,562
| +21% | +$56.2K | 0.04% | 832 |
|
|
2021
Q4 | $350K | Sell |
12,335
-4,145
| -25% | -$118K | 0.04% | 834 |
|
|
2021
Q3 | $347K | Buy |
+16,480
| New | +$347K | 0.04% | 917 |
|